Compare SGMO & STEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SGMO | STEX |
|---|---|---|
| Founded | 1995 | 2009 |
| Country | United States | United States |
| Employees | 183 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 135.1M | 127.3M |
| IPO Year | 2000 | N/A |
| Metric | SGMO | STEX |
|---|---|---|
| Price | $0.41 | $3.51 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $5.60 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 4.2M | 691.6K |
| Earning Date | 11-06-2025 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $32,875,000.00 | $13,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.38 | $0.40 |
| 52 Week High | $1.40 | $14.11 |
| Indicator | SGMO | STEX |
|---|---|---|
| Relative Strength Index (RSI) | 38.99 | N/A |
| Support Level | $0.43 | N/A |
| Resistance Level | $0.48 | N/A |
| Average True Range (ATR) | 0.03 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 8.32 | 0.00 |
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
Streamex Corp is a vertically integrated technology and infrastructure company. It is focused on the tokenization and digitalization of real-world assets. The group provides institutional-grade solutions that bring traditional commodities and assets on-chain through secure, regulated, and yield-bearing financial instruments. It is committed to delivering transparent, scalable, and compliant digital asset solutions that bridge the gap between traditional finance and blockchain-enabled markets.